Form 4: Exagen Director Receives Stock Grant
Insider Transaction (Form 4)
Paul Kim, a Director of Exagen Inc., received 37,500 shares of common stock on June 9, 2026.
Summary
- Grant/award: acquired 37,500 Stock Option(right to buy) on June 9, 2026; holds 46,500 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Paul Kim — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-06-09 | Grant/award | Stock Option(right to buy) | 37,500 | — | — | 46,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-06-09 | Grant/award (37,500 shares) |
Keywords
insider transaction, Form 4, XGN, EXAGEN INC., neutral, Paul Kim
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.